prime stocks Archives - Page 6 of 10

Prime Stock Recommendation: An R&D focused company in the API space

N V Chandrachoodamani / Stocks, Categories, Premium, Research Reports / May 7, 2023

It has been a rough ride for the Indian API industry in the past 2 years. A combination of factors including price erosion in US generics, destocking, demand fluctuation, elevated raw material costs and freight costs have hit the margins of many API plays including market favourites such as Divi’s, Laurus and Aarti Drugs. Their growth has also remained at low single digits in this period.
Still, if a company has managed to remain resilient in this period and yet corrected to valuations that make it attractive, it deserves to be noticed.

Premium article available only to subscribers.

Prime Stock Recommendation: An R&D focused company in the API space Read More »

Stock alert: Narratives and numbers – what to do with Infosys?

Vidya Bala / Stocks, Categories, Premium / April 20, 2023

A 14% fall in INFOSYS (INFY) in just a week is not something that you expect, especially when the index itself fell under 1% over the same period. But then, when markets are disappointed, they don’t cry, they rage.

Premium article available only to subscribers.

Stock alert: Narratives and numbers – what to do with Infosys? Read More »

Prime Stock recommendation: A pharma stock available at a bargain

Pavithra Jaivant / Stocks, Categories, Premium / April 16, 2023

Picking a stock in the pharma space is not easy. The businesses are complex and can leave you feeling like you are preparing for a mini-MBBS. What’s more – no two companies are alike. To compound matters, it is also a heavily regulated space (and rightly so) with complex supply chains very often, heavily reliant on China. Not only do most end products have names that sound like tongue twisters but can be governed by complex patent regulations.

Premium article available only to subscribers.

Prime Stock recommendation: A pharma stock available at a bargain Read More »

Entering a stock at peak valuation? – 5 questions to ask

N V Chandrachoodamani / Stocks, Categories, Markets / April 11, 2023

When markets make merry, many stocks have seemingly compelling stories even for entering at peak valuation. And the market is fine with stretched valuations to accommodate such stories. In other words, every market-favoured stock appears to scream – buy me at any price.

But when challenges emerge, the same market starts reacting so sharply that investors who bought into the story midway start making losses. Yes, there isn’t a bigger disaster for stock market investors than earnings and PE multiples contracting together.

Entering a stock at peak valuation? – 5 questions to ask Read More »

Prime Stock: An averaging call on this fashion player

N V Chandrachoodamani / Stocks, Categories, Premium / March 28, 2023

In February last year, we had issued a buy call on the stock of a premier fashion player housing a vast number of national brands. The steps this company had taken to expand its offering range, a return of focus on margins, and the consumption promise all propelled the call. the stock rallied handsomely as well, post our call.
However, owing to two factors, the stock has since given up nearly 40% from its high and is currently about 25% below our original call price.

Prime Stock: An averaging call on this fashion player Read More »

Prime Stock alert: Shifting this auto stock from HOLD to BUY

N V Chandrachoodamani / Stocks, Categories, Premium / March 28, 2023

Indian markets have corrected about 10% (Nifty 50) from the last peak in December 2022. But many stocks have fallen much more than the bellwether index. This has provided an opportunity to revisit some of our recommended stocks – to either identify averaging opportunities or move them to a BUY from a HOLD.

Premium article available only to subscribers.

Prime Stock alert: Shifting this auto stock from HOLD to BUY Read More »

Prime Stock recommendation: A promising play on food security

PrimeInvestor Research Team / Stocks, Categories, Premium / March 14, 2023

Recent instances of countries rationing food supplies on import disruptions and grappling with hyper-inflation, have prompted governments the world over to refocus on food security. With limited supply of arable land and water, the key to achieving food security lies in improving crop yields. In India, there’s a crying need to improve yields not only to secure food supplies for the domestic population, but also to cater to global export opportunities for farm products, that are at an inflection point. Companies engaged in crop protection, fertilizer and hybrid seeds are positioned to make the most of these tailwinds.
But if you’re an Indian investor looking to make a long-term bet on this theme, your options aren’t very many. There are about 20 listed companies in the fertilizer space. But the sector makes for a poor investment because of whimsical government policies that hamper growth and profitability. Listed crop protection and seed companies offer superior options. Listed agrochem players offer choices from micro to large players, with differing business models that focus on generic agrochemicals, interm

Premium article available only to subscribers.

Prime Stock recommendation: A promising play on food security Read More »

Prime stock update: Are we still sweet on this sugar maker?

Pavithra Jaivant / Stocks, Categories, Premium / March 9, 2023

In August 2021, we recommended a sugar manufacturer, well placed to play the ethanol opportunity that was set to change the dynamics of the sugar sector in India. 18 months down the line, the ethanol opportunity has played out as we expected and we have more clarity on this front. But at the same time, stock returns for our chosen candidate stand at just ~5% since our ‘BUY’ recommendation even though it rallied over 30% and also fell by almost 20% in the interim. We think, this calls for an update.

Premium article available only to subscribers.

Prime stock update: Are we still sweet on this sugar maker? Read More »

Prime stocks update: An exit call on an insurance stock

N V Chandrachoodamani / Stocks, Categories, Premium, Research Reports / March 1, 2023

In April 2022, we had issued a buy recommendation on a general insurance player, as both the industry and the company itself were emerging from the Covid-driven impact and were poised for growth. Since then, however, the insurance sector has lost market favour as growth has not panned out as expected.

Premium article available only to subscribers.

Prime stocks update: An exit call on an insurance stock Read More »

Prime Stocks update: Moving this biotech stock from BUY to a HOLD

N V Chandrachoodamani / Stocks, Categories, Premium, Research Reports / March 1, 2023

When we gave the call of this R&D focused company engaged in the manufacture of enzymes and probiotics, the company had Covid-related challenges but showed promise of growth. It was later also pulled down by consolidation of acquisitions and costs related to new product launches. We therefore knew that the call would take longer to pay off. The stock went through a significant correction after our initial recommendation as earnings disappointed.

Premium article available only to subscribers.

Prime Stocks update: Moving this biotech stock from BUY to a HOLD Read More »

Prime Stock update: Prospects brighten for our small finance bank call

N V Chandrachoodamani / Stocks, Categories, Premium / February 19, 2023

Covid proved be an ultimate stress test for Small Finance Banks (SFBs). As SFBs largely cater to low income borrowers comprising small businesses, small vehicle owners and other self-employed categories including micro-finance, they were among the most Covid-sensitive sectors.

Premium article available only to subscribers.

Prime Stock update: Prospects brighten for our small finance bank call Read More »

Prime Stocks update: How this EV player is placed now

N V Chandrachoodamani / Stocks, Categories, Premium, Research Reports / January 26, 2023

We had, in mid-2021, initiated a buy call on a stock that was reinventing itself from a supplier of diesel engines into an EV player. It was an early call we’d made on the EV boom, which appears well-timed as electric 2-wheeler sales jumped from 16,000 units in 2018 to 150,000 units in 2021 to a whopping 615,000 units in 2022!
With the EV 2-wheeler market now clearly segmenting itself, there is more clarity on how competition and market share is shaping up. The EV 2-wheeler industry is also going through regulatory tightening.

Premium article available only to subscribers.

Prime Stocks update: How this EV player is placed now Read More »

prime stocks

Become a PrimeInvestor!